FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216329307> ?p ?o ?g. }

• W3216329307 endingPage "175883592110598" @default.
• W3216329307 startingPage "175883592110598" @default.
• W3216329307 abstract "Ovarian cancer (OvCa) constitutes a rare and highly aggressive malignancy and is one of the most lethal of all gynaecologic neoplasms. Due to chemotherapy resistance and treatment limitations because of side effects, OvCa is still not sufficiently treatable. Hence, new drugs for OvCa therapy such as P8-D6 with promising antitumour properties have a high clinical need. The benzo[c]phenanthridine P8-D6 is an effective inductor of apoptosis by acting as a dual topoisomerase I/II inhibitor.In the present study, the effectiveness of P8-D6 on OvCa was investigated in vitro. In various OvCa cell lines and ex vivo primary cells, the apoptosis induction compared with standard therapeutic agents was determined in two-dimensional monolayers. Expanded by three-dimensional and co-culture, the P8-D6 treated cells were examined for changes in cytotoxicity, apoptosis rate and membrane integrity via scanning electron microscopy (SEM). Likewise, the effects of P8-D6 on non-cancer human ovarian surface epithelial cells and primary human hepatocytes were determined.This study shows a significant P8-D6-induced increase in apoptosis and cytotoxicity in OvCa cells which surpasses the efficacy of well-established drugs like cisplatin or the topoisomerase inhibitors etoposide and topotecan. Non-cancer cells were affected only slightly by P8-D6. Moreover, no hepatotoxic effect in in vitro studies was detected.P8-D6 is a strong and rapid inductor of apoptosis and might be a novel treatment option for OvCa therapy." @default.
• W3216329307 created "2021-12-06" @default.
• W3216329307 creator A5022476633 @default.
• W3216329307 creator A5059141348 @default.
• W3216329307 creator A5068115355 @default.
• W3216329307 creator A5070867470 @default.
• W3216329307 creator A5079220895 @default.
• W3216329307 creator A5080994672 @default.
• W3216329307 creator A5090451964 @default.
• W3216329307 date "2021-01-01" @default.
• W3216329307 modified "2023-09-23" @default.
• W3216329307 title "Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer" @default.
• W3216329307 cites W111438725 @default.
• W3216329307 cites W1496060302 @default.
• W3216329307 cites W1496626589 @default.
• W3216329307 cites W1952453258 @default.
• W3216329307 cites W1967921904 @default.
• W3216329307 cites W1984242958 @default.
• W3216329307 cites W1985550031 @default.
• W3216329307 cites W1987516501 @default.
• W3216329307 cites W1991052457 @default.
• W3216329307 cites W1996610990 @default.
• W3216329307 cites W2013838894 @default.
• W3216329307 cites W2025023091 @default.
• W3216329307 cites W2048459104 @default.
• W3216329307 cites W2050448027 @default.
• W3216329307 cites W2054837357 @default.
• W3216329307 cites W206131514 @default.
• W3216329307 cites W2063354329 @default.
• W3216329307 cites W2070932606 @default.
• W3216329307 cites W2098038647 @default.
• W3216329307 cites W2121454394 @default.
• W3216329307 cites W2132740911 @default.
• W3216329307 cites W2140279988 @default.
• W3216329307 cites W2154885792 @default.
• W3216329307 cites W2255406080 @default.
• W3216329307 cites W2260195491 @default.
• W3216329307 cites W2331628193 @default.
• W3216329307 cites W2363777001 @default.
• W3216329307 cites W2404152963 @default.
• W3216329307 cites W2579801053 @default.
• W3216329307 cites W2779061198 @default.
• W3216329307 cites W2885196309 @default.
• W3216329307 cites W2900056609 @default.
• W3216329307 cites W2903868029 @default.
• W3216329307 cites W2975140046 @default.
• W3216329307 cites W2978001861 @default.
• W3216329307 cites W2980164919 @default.
• W3216329307 cites W2999417355 @default.
• W3216329307 cites W3013676709 @default.
• W3216329307 cites W3026537529 @default.
• W3216329307 cites W3120778227 @default.
• W3216329307 cites W3135685350 @default.
• W3216329307 cites W3159777004 @default.
• W3216329307 cites W4237125941 @default.
• W3216329307 doi "https://doi.org/10.1177/17588359211059896" @default.
• W3216329307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34887943" @default.
• W3216329307 hasPublicationYear "2021" @default.
• W3216329307 type Work @default.
• W3216329307 sameAs 3216329307 @default.
• W3216329307 citedByCount "3" @default.
• W3216329307 countsByYear W32163293072021 @default.
• W3216329307 countsByYear W32163293072022 @default.
• W3216329307 countsByYear W32163293072023 @default.
• W3216329307 crossrefType "journal-article" @default.
• W3216329307 hasAuthorship W3216329307A5022476633 @default.
• W3216329307 hasAuthorship W3216329307A5059141348 @default.
• W3216329307 hasAuthorship W3216329307A5068115355 @default.
• W3216329307 hasAuthorship W3216329307A5070867470 @default.
• W3216329307 hasAuthorship W3216329307A5079220895 @default.
• W3216329307 hasAuthorship W3216329307A5080994672 @default.
• W3216329307 hasAuthorship W3216329307A5090451964 @default.
• W3216329307 hasBestOaLocation W32163293071 @default.
• W3216329307 hasConcept C109316439 @default.
• W3216329307 hasConcept C121608353 @default.
• W3216329307 hasConcept C126322002 @default.
• W3216329307 hasConcept C147897179 @default.
• W3216329307 hasConcept C150903083 @default.
• W3216329307 hasConcept C190283241 @default.
• W3216329307 hasConcept C202751555 @default.
• W3216329307 hasConcept C207001950 @default.
• W3216329307 hasConcept C2776694085 @default.
• W3216329307 hasConcept C2778119113 @default.
• W3216329307 hasConcept C2778239845 @default.
• W3216329307 hasConcept C2778616834 @default.
• W3216329307 hasConcept C2780427987 @default.
• W3216329307 hasConcept C2781209748 @default.
• W3216329307 hasConcept C2781451048 @default.
• W3216329307 hasConcept C502942594 @default.
• W3216329307 hasConcept C55493867 @default.
• W3216329307 hasConcept C71924100 @default.
• W3216329307 hasConcept C86803240 @default.
• W3216329307 hasConcept C98274493 @default.
• W3216329307 hasConceptScore W3216329307C109316439 @default.
• W3216329307 hasConceptScore W3216329307C121608353 @default.
• W3216329307 hasConceptScore W3216329307C126322002 @default.
• W3216329307 hasConceptScore W3216329307C147897179 @default.
• W3216329307 hasConceptScore W3216329307C150903083 @default.

• next